Tacrolimus .5 mg/1

Tacrolimus .5 mg capsules are an immunosuppressant medication used to prevent organ rejection after transplants. This oral medication is manufactured by Mylan Pharmaceuticals Inc. in the USA.

Tacrolimus .5 mg capsules are primarily used to prevent the body from rejecting a transplanted organ, such as a kidney, liver, or heart. This medication works by suppressing the immune system to reduce the risk of organ rejection. Tacrolimus is often prescribed as part of a broader treatment plan following transplant surgery. It is important to follow the guidance of a healthcare provider when using this medication.

Common effects of Tacrolimus .5 mg capsules may include headaches, tremors, and gastrointestinal issues such as nausea or diarrhea. Some individuals may also experience increased blood pressure or changes in kidney function. It is essential to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Tacrolimus .5 mg capsules should be handled with care, as they are potent immunosuppressants. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional. Avoid grapefruit and grapefruit juice, as they can interact with Tacrolimus. Regular monitoring of blood levels and kidney function is often recommended.

Tacrolimus .5 mg capsules can interact with various medications, including other immunosuppressants, antifungal agents, and certain antibiotics. Alcohol and grapefruit products can also affect the metabolism of Tacrolimus. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.